Xu Liu
Beijing, 100044, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Efficacy of Qingrehuoxue granule for bone protection in patients with active rheumatoid arthritis in China: The PRE-ERODE randomized controlled trial.
Journal: Journal of ethnopharmacology
Published: April 15, 2025
Clinical significance of serum RAGE levels in anti-CCP-negative rheumatoid arthritis.
Journal: Clinical rheumatology
Published: March 16, 2025
Proinflammatory phenotype of B10 and B10pro cells elicited by TNF-α in rheumatoid arthritis.
Journal: Annals of the rheumatic diseases
Published: August 19, 2023
Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome: A Randomized Clinical Trial.
Journal: JAMA network open
Published: November 10, 2022
Antibody to peptidoglycan recognition protein (PGLYRP)-2 as a novel biomarker in rheumatoid arthritis.
Journal: Clinical and experimental rheumatology
Published: April 23, 2020
Scavenger receptor-A is a biomarker and effector of rheumatoid arthritis: A large-scale multicenter study.
Journal: Nature communications
Published: April 25, 2019
Increased Interleukin-17F is Associated with Elevated Autoantibody Levels and More Clinically Relevant Than Interleukin-17A in Primary Sjögren's Syndrome.
Journal: Journal of immunology research
Published: August 15, 2016
Hypoxia-inducible factor-1α perpetuates synovial fibroblast interactions with T cells and B cells in rheumatoid arthritis.
Journal: European journal of immunology
Published: May 06, 2015
The Clinical Relevance of IL-17-Producing CD4+CD161+ Cell and Its Subpopulations in Primary Sjögren's Syndrome.
Journal: Journal of immunology research
Published: April 15, 2015
Establishment of a novel diagnostic model for Sjögren's syndrome by proteomic fingerprinting.
Journal: Clinical rheumatology
Published: June 21, 2014
Last Updated: 09/26/2026